Hourly refreshSat, Sep 12, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Healthcare

7,169 press releases indexed under healthcare.

AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
DownloadExcelTXT
Finance · Healthcare

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PRINCETON, N.J., Sept. 04, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (“RSUs”) to 19 new employees in connection with their employment with UroGen. These new team members will support the ongoing commercialization of JELMYTO ® (mitomycin) for pyelocalyceal solution and ZUSDURI™ (mitomycin) for intravesical solution, UroGen’s only approved products, and the continued development of UroGen’s pipeline.

Sep 4 · 12:00GlobeNewswire
Healthcare

Orbis Flying Eye Hospital Marks 20 Years of Partnership with Macau

First-ever Flying Eye Hospital training project in Macau, supported by Alcon and OMEGA, highlights two decades of local support advancing eye health in China and around the world. MACAU, Sept. 4, 2026 /PRNewswire/ -- Global eye care nonprofit Orbis International is celebrating 20 years of...

Sep 4 · 11:57PR Newswire
Healthcare

Landmark Grant Paves the Way for Animal-Free Leukaemia Research

Friday 4 September, 2026 New research could transform the way scientists study leukaemia while reducing the need for animals in research A major new research grant aiming to improve our understanding of leukaemia while reducing the use of animals in science has been announced today to mark World Leukaemia Day (4 September). Funded by The Humane Research Trust, with support from Naturewatch Foundation, the £450,000 grant will enable Dr Minerva Bosch-Fortea at Barts Cancer Institute to develop a pioneering 100% animal-free model of the leukaemia bone marrow environment. Leukaemia affects thousands of people across the UK every year, with around 9,900 new cases diagnosed annually - equivalent to around 27 people every day. Despite advances in treatment, treatment resistance remains a major ch

Sep 4 · 11:48Pressat
Healthcare

Two Weill Cornell Medicine Pediatricians the First to Offer Families Enhanced Support Through the Pediatric Concierge Medicine Program from Concierge Choice Physicians

Innovative healthcare model emphasizes a more personalized, convenient approach to pediatric care ROCKVILLE CENTRE, N.Y., Sept. 4, 2026 /PRNewswire/ -- Concierge Choice Physicians (CCP), the nation's leading full-service concierge medical service provider, announced today that two...

Sep 4 · 11:30PR Newswire
Healthcare

WHO validates Bhutan for eliminating dog-transmitted human rabies

The World Health Organization (WHO) has validated Bhutan's elimination of dog-transmitted rabies as a public health problem in the country. Bhutan is the first country in the WHO South-East Asia Region to achieve this success. - - Rabies is a viral disease that is almost always fatal once clinical symptoms appear. However, rabies deaths are preventable. On one hand, vaccinating dogs curbs the disease at its source; on the other, prompt use of post exposure prophylaxis (PEP) stops the virus... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=360023

Sep 4 · 11:20WebWire
Healthcare · Education

Arup helps deliver country's first NHS National Rehabilitation Centre

Arup has helped deliver the country's first purpose-built National Rehabilitation Centre (NRC) for NHS patients. Run and staffed by Nottingham University Hospitals NHS Trust (NUH), the new facility will provide specialist rehabilitation care for people recovering from life changing injuries and illnesses. - - Located near Loughborough, UK, the £105 million, 70 bed centre is part of the Government's New Hospital Programme which aims to renew the NHS estate while improving patient safety and... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=360019

Sep 4 · 11:10WebWire
Finance · Healthcare

Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences

WALTHAM, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune and inflammatory diseases, today announced management’s presentations at the following investor conferences:

Sep 4 · 11:05GlobeNewswire
AI · Healthcare

Trustpoint Xposure, the First AEO-Certified PR Agency, Releases 2026 ...

(PR-inside.com) Internal data from more than 200 professional AI citation audits documents a widening gap between brands working under a documented five-signal AEO methodology and brands working with agencies that claim AEO without a documented standard, identifying specific performance differences across legal, medical, financial, and technology sectors. AMHERST, NY / ACCESS Newswire / September 4, 2026 / Trustpoint Xposure, the first AEO-certified PR agency in the United States , today released its 2026 State of AEO Report, a comprehensive internal analysis documenting the performance gap between certified and uncertified AEO methodology across legal, medical, financial, and technology professional categories. The report draws on ..

Sep 4 · 11:03PR-Inside
Finance · Healthcare

Pomerantz LLP Announces The Filing of a Class Action Against Fractyl ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 4, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ:GUTS) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-07167, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fractyl securities between January 13, 2025 and January 29, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations ..

Sep 4 · 11:02PR-Inside
Healthcare

Acepodia Announces FDA Clearance of IND Application for ACE723, a Novel Dual-Payload Antibody-Drug Conjugate

FDA clearance enables initiation of a Phase 1 clinical trial and advances the first AD2C-generated candidate into clinical development ALAMEDA, Calif. and TAIPEI, Sept. 4, 2026 /PRNewswire/ -- Acepodia (6976: TT), a clinical-stage biotechnology company developing next-generation cell...

Sep 4 · 11:00PR Newswire
Finance · Healthcare

BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier

BioStem Technologies Expands Contracts with Two of the Largest Group Purchasing Organizations in the United States

Sep 4 · 11:00GlobeNewswire
Healthcare

DIMERIX SECURES A$34 MILLION NON-DILUTIVE FACILITY TO FUND KEY CLINICAL MILESTONES

Dimerix successfully enters into non-dilutive facility agreements to access A$34 million[1] with a syndicate of Australian and U.S. independent lenders, including the previously announced initial facility of A$10 million[2] Facility terms for all Lenders substantially consistent with the...

Sep 4 · 11:00PR Newswire
← Prev123598Next →